contemporarypediatrics2 天
Anna Reed, MD, MPH
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics2 天
Maria D McColgan, MD, MSEd, FAAP
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics2 天
Nathan Hitzeman, MD
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics3 天
FDA approves first generic GLP-1 injection for type 2 diabetes in patients 10 years and up
The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up. The US Food and Drug Administration (FDA) has ...
contemporarypediatrics3 天
FDA approves concizumab-mtci prophylaxis for hemophilia A and B
The indication is for patients 12 years and older hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors. The FDA has approved concizumab-mtci (Alhemo; Novo Nordisk) in ...
contemporarypediatrics3 天
Michael I. Reiff, MD
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics6 天
FDA expands setmelanotide indication to patients as young as 2 years
The expanded indication is approved to reduce excess body weight and maintain reduction long-term in children 2 years and up with obesity due to BBS, POMC, or LEPR deficiency. The FDA has approved an ...
contemporarypediatrics6 天
Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial
Positive phase 3 data for inhaled insulin Afrezza Inhalation Powder (MannKind Corporation) in children and adolescents aged 4 to 17 years has been announced by MannKind Corporation. 1 According to the ...
contemporarypediatrics6 天
Lawrence Eichenfield, MD, talks tapinarof cream, 1%, nemolizumab FDA approvals for atopic ...
"Tapinarof comes in with that mixture of the short-term studies and longer-term studies intermittently, giving us a nice, effective alternative non-steroid for eczema across the ages." Lawrence ...
contemporarypediatrics7 天
Understanding pediatric ED readiness: Quartiles, disparities, and cost
Nathan Kuppermann, MD, MPH, explains the different quartiles of the pediatric emergency department readiness scale, and why the top tier is so crucial for pediatric patients. Nathan Kuppermann, MD, ...
contemporarypediatrics8 天
FDA approves remestemcel-L-rknd to treat steroid-refractory acute graft-versus-host disease
Ahead of the January 7, 2025 prescription drug user act fee date, the FDA has granted approval to Mesoblast's remestemcel-L-rknd (Ryoncil) for the treatment of steroid-refractory acute ...
contemporarypediatrics7 天
Healthy prenatal diet could be upstream obesity prevention strategy
"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ...